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Studies of cell inactivation kinetics by anticancer
agents are important in providing a rational basis
for treatment schedules. For several years, we have
reported various aspects of the survival response of
mammalian cells to Bleomycin (BLM) (Terasima et
al., 1972; Takabe et al., 1977). The dose-survival
response of cells to BLM was characterized by an
upward concave or a biphasic curve; cells were
sensitive at lower concentrations and less sensitive
at higher concentrations. In studies of the time-
survival response of cells, BLM induced substantial
resistance to cells after initial rapid cell killing,
resulting in a biphasic curve. However, the nature
of the resistance remains to be solved. In the
present paper, we report repair of cells in the
presence of BLM, which caused the resistance seen
in time- and dose-survival curves.
HeLa S3 cells were cultured in F-10 medium
(Ham, 1963) supplemented with 10% calf serum
and antibiotics. To obtain cells in exponential and
plateau phase growth, cells were inoculated into
plastic petri dishes (Falcon, 60mm, diam.) at a cell
density of 105 cells per dish and incubated in a
C02-chamber at 37°C.
Medium was renewed daily from the 3rd to the
14th day of culture. Under these conditions, cells
grew exponentially with a generation time of 20h
for the first 4 days. This was followed by a gradual
reduction in the growth rate for the next 3 days.
Cell number plateaued at -2.0 x 107 per dish and
was sustained for the next 8 days. In time- and
dose-survival experiments, cells at the 2nd
(exponential phase) and the 14th day (plateau
phase) of culture were exposed to Bleomycin-A2
(BLM). The culture medium was replaced with
medium containing BLM and then the cells were
incubated for various lengths of time. The drug
exposure was terminated by rinsing the cells twice
with FlO medium. Immediately after this, the cells
were dispersed with 0.1% trypsin, plated into dishes
and incubated for colony growth.
In addition, a single cell plating technique (Puck
& Markus, 1956; Terasima et al., 1972) was
employed to determine cell survival. Briefly,
exponentially growing cells were dispersed with
0.1% trypsin to produce single cell suspensions.
The suspended cells were plated into plastic dishes
after appropriate dilutions. At 4-5h after
incubation, individual cells had attached firmly to
the bottom of the dishes. Next, the cells were
exposed to BLM by replacing the growth medium
in the dishes with medium containing BLM for
periods ranging from 1 to 15min. Drug-exposure
was terminated by washing the cultures twice with
FI0 medium. Fresh, drug-free growth medium was
added to the dishes and cells were allowed to grow
and form colonies.
As shown in Figure 1, cells at exponential and
plateau phase of growth were exposed to
lOugml-P of BLM for 2.5, 5.0, 7.5, 15, 30 and
60min. The resulting survival curve of exponential
cells exhibited a triphasic shape. Initially, cells were
rapidly killed during the first 7.5min (the first
phase). This was followed by quick recovery lasting
for the next 7.5min (the second phase), which
occurred despite of the presence of BLM. After this
period, cell killing continued for the remaining
exposure period (the third phase). The shape of the
survival curve for plateau phase cells was similar to
that of exponentially growing cells. Figure 1 also
shows that plateau phase cells are more sensitive
than exponentially growing cells and that this
cannot be attributed to lack of repair but instead to
the enhancement of the first rapid phase of cell
killing.
Dose-survival curves of the cells exposed to BLM
are shown in Figure 2. Cells in plateau phase were
exposed to graded concentrations of BLM for 2.5,
7.5 and 60min. Survival curves of plateau phase
cells exposed to the drug for 60min (open circles)
showed an upward concavity. Plateau phase cells
exposed to graded concentrations of the drug for
2.5min (open triangles) and 7.5min (open squares)
are also shown in Figure 2. Plateau phase cells
exposed to the drug for short times showed
exponential cell killing. This was also the case with
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Figure 1 Time-Survival Curve. Cells at exponential
(E) and plateau (0) phases were exposed to
IOpgml-1 of BLM for 2.5, 5.0, 7.5, 15, 30 and 60min.
Vertical bars indicate +s.d. of 6 and 4 replicate
experiments for exponential and plateau phase cells,
respectively. Cells obtained with the single cell plating
technique (A) were also exposed to 10pgml-' of
BLM for 1.0, 2.5, 5.0, 7.5 and 15min. Vertical bars
indicate +s.d. of 7 replicate experiments.
exponential cells exposed to the drug for the same
short exposure times (data not shown). These
results clearly indicate that the resistant portion of
the biphasic dose-response curve for a 60min
exposure was the result of survival recovery seen in
the time-survival response and implies that the
capability of repair may be drug-concentration
dependent.
In addition to the biphasic dose-survival curve
for cells exposed to BLM, biphasic time-survival
curves have been reported previously (Barranco &
Humphrey, 1971; Braun & Hahn, 1975; Mauro et
al., 1974; Terasima et al., 1972). In those reports,
time-survival points were obtained at longer
exposure times than the times used in this study, so
that there was no detectable dip in survival. The
triphasic time-survival curve in the present paper
may be the composite of two cellular processes.
BLM has the potential to sterilize cells even during
short exposure times, but it can also induce repair
processes which moderate the expression of this
injury, resulting in the third phase of slope in the
curve.
The primary cytotoxic action of BLM on cells is
thought to involve the breaking of DNA strands
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Figure 2 Dose-Survival Curve. Cells at plateau phase
(0) were exposed to graded concentrations of BLM
for 60min. Vertical bars indicate +s.d. of 4 replicate
experiments. The cells were also exposed to graded
concentrations of the drug for 2.5min (A) and 7.5min
(El). Each point represents the mean of 3 replicate
dishes from one experiment.
(Umezawa, 1976). DNA strand breakage has been
shown to be efficiently repaired (Terasima et al.,
1970). Using cultured mouse L cells, we also
examined changes in the mol. wt of DNA by single-
strand breaks as a function of exposure time to
BLM (Terasima et al., 1979). The mol. wt decreased
rapidly within the first 5min and was followed by
rapid repair which rejoined the breaks within the
next 15 to 30min. Such a pattern of change in
molecular DNA is chronologically similar to
changes in cell survival after drug exposure.
Accordingly, it is suggested that repair enzymes for
DNA strand breaks operate only when cells are
exposed to BLM. BLM has been shown to
specifically act on some DNA sequences which
resulted in double-strand breaks (Mirabelli et al.,
1982; Miyaki et al., 1974). The double-strand
breaks were partially repaired beginning more than
30min after drug removal. This was somewhat later
than for the completion of repair of single-strand
breaks. When cell exposed to BLM were
simultaneously or post-treated with hyperthermia
(Braun & Hahn, 1975), ethanol (Mizuno, 1981) and
local anaesthetics (Mizuno & Ishida, 1982), the
shape of the time-survival curves for BLM changed
from biphasic to exponential. It appears that
recovery from BLM exposure (Figure 1) may be
inhibited by these agents through the modification
of membrane function, which is thought to be
closely associated with the repair of double-strand
breaks (Miyaki et al., 1974).NEW REPAIR OF BLEOMYCIN DAMAGE 249
Several reports (Takabe et al., 1974; Twentyman
& Bleehen, 1975) have described results in which
cells, exposed to potentially lethal doses of BLM,
repaired that damage when in various
environmental conditions. BLM has been shown to
induce potentially lethal damage (PLD) repair
within a very short time after removal of the drug
even in exponentially growing cell cultures
(Barranco & Bolton, 1977). PLD repair may occur
even during the trypsinization period immediately
after drug removal. In order to exclude this
possibility, we generated time-survival curve for
BLM by the single cell plating technique mentioned
above, which clearly showed that there was a
transient drop in cell survival after 2.5 min drug-
exposure as shown in Figure 1.
Strictly speaking, it is possible that the cells may
have recovered from BLM-induced PLD even in
this experimental system. However, this does not
seem to be true. In a previous paper (Terasima et
al., 1972), we conducted two-dose fractionation
experiments using the same experimental system.
Cell exposure time of 120min to 51tgml-1 of BLM
was divided into two equal fractions of 60min-
exposure time separated by various time intervals
from 0 to 10h. The survival of L cells exposed to
the first exposure time did not increase during this
period, indicating that there was no induction of
PLD repair. As the time interval between the first
and second dose was lengthened, cell survival
decreased in cells given the fractionated dose
compared to those exposed continuously, implying
that the resistance induced by the first dose decayed
gradually after removal of BLM and finally
disappeared after more than 4h. In the present
study, resistance is seen as the result of quick repair
subsequent to an initial period of rapid cell killing.
Decay of resistance would be the consequence of a
decrease in repair.
In summary, quick repair was induced only in
BLM exposed cells and decayed after removal of
the drug, which is kinetically opposite to PLD
repair. Residual repair after removal of BLM was
detected only after re-exposure to BLM. Based on
these findings, quick repair is provisionally
described here as a new type of cell recovery from
BLM-induced cellular damage.
We wish to thank Ms. N. Naka for her excellent help in
preparing this manuscript.
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